These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 16528552)
1. Quality of life of patients with keloid and hypertrophic scarring. Bock O; Schmid-Ott G; Malewski P; Mrowietz U Arch Dermatol Res; 2006 Apr; 297(10):433-8. PubMed ID: 16528552 [TBL] [Abstract][Full Text] [Related]
2. Treatment of keloids and hypertrophic scars with dermojet injections of bleomycin: a preliminary study. Saray Y; Güleç AT Int J Dermatol; 2005 Sep; 44(9):777-84. PubMed ID: 16135153 [TBL] [Abstract][Full Text] [Related]
3. Treatment of hypertrophic scars and keloids using intense pulsed light (IPL). Erol OO; Gurlek A; Agaoglu G; Topcuoglu E; Oz H Aesthetic Plast Surg; 2008 Nov; 32(6):902-9. PubMed ID: 18560927 [TBL] [Abstract][Full Text] [Related]
4. Developing a quality of life instrument in patients with psoriasis: the Psoriasis Quality of Life Questionnaire (PQLQ). Inanir I; Aydemir O; Gündüz K; Danaci AE; Türel A Int J Dermatol; 2006 Mar; 45(3):234-8. PubMed ID: 16533221 [TBL] [Abstract][Full Text] [Related]
5. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample. Park KU Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Evers AW; Duller P; van de Kerkhof PC; van der Valk PG; de Jong EM; Gerritsen MJ; Otero E; Verhoeven EW; Verhaak CM; Kraaimaat FW Br J Dermatol; 2008 Jan; 158(1):101-8. PubMed ID: 17999699 [TBL] [Abstract][Full Text] [Related]
7. A valid and reliable measure of constipation-related quality of life. Wang JY; Hart SL; Lee J; Berian JR; McCrea GL; Varma MG Dis Colon Rectum; 2009 Aug; 52(8):1434-42. PubMed ID: 19617757 [TBL] [Abstract][Full Text] [Related]
9. [Disease-specific Questionnaire for Quality of Life in Patients with Peripheral Arterial Occlusive Disease in the Stage of Critical Ischemia (FLeQKI)--methodical development of a specific measuring instrument and psychometric evaluation of its validity and reliability (Part 1)]. Wohlgemuth WA; Olbricht W; Klarmann S; Engelhardt M; Freitag MH; Wölfle K; Bohndorf K; Kirchhof K Rofo; 2007 Dec; 179(12):1251-7. PubMed ID: 18004695 [TBL] [Abstract][Full Text] [Related]
10. Intralesional triamcinolone alone or in combination with 5-fluorouracil for the treatment of keloid and hypertrophic scars. Darougheh A; Asilian A; Shariati F Clin Exp Dermatol; 2009 Mar; 34(2):219-23. PubMed ID: 19018794 [TBL] [Abstract][Full Text] [Related]
11. The dermatology life quality index as a means to assess life quality in patients with different scar types. Reinholz M; Poetschke J; Schwaiger H; Epple A; Ruzicka T; Gauglitz GG J Eur Acad Dermatol Venereol; 2015 Nov; 29(11):2112-9. PubMed ID: 25866177 [TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of the quality of life instrument in chronic liver disease patients with minimal hepatic encephalopathy. Zhou YQ; Chen SY; Jiang LD; Guo CY; Shen ZY; Huang PX; Wang JY J Gastroenterol Hepatol; 2009 Mar; 24(3):408-15. PubMed ID: 19054261 [TBL] [Abstract][Full Text] [Related]
13. Intra-lesional injections of collagenase are ineffective in the treatment of keloid and hypertrophic scars. Kang N; Sivakumar B; Sanders R; Nduka C; Gault D J Plast Reconstr Aesthet Surg; 2006; 59(7):693-9. PubMed ID: 16782564 [TBL] [Abstract][Full Text] [Related]
14. [Nerve regeneration of hypertrophic scars and keloids after deep burns]. Song Y; Cen Y; Xen XW; Liu Y Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Nov; 36(6):797-9. PubMed ID: 16334556 [TBL] [Abstract][Full Text] [Related]
15. Psychometric testing and validation of the Chronic Pain Sleep Inventory. Kosinski M; Janagap CC; Gajria K; Schein J Clin Ther; 2007; 29 Suppl():2562-77. PubMed ID: 18164922 [TBL] [Abstract][Full Text] [Related]
16. Construction and validation of a patient-reported outcome dedicated to chronic venous disorders: SQOR-V (specific quality of life and outcome response - venous). Guex JJ; Zimmet SE; Boussetta S; Nguyen C; Taieb C J Mal Vasc; 2007 Jul; 32(3):135-47. PubMed ID: 17616292 [TBL] [Abstract][Full Text] [Related]
17. Validity of the new Backache Index (BAI) in patients with low back pain. Farasyn A; Meeusen R Spine J; 2006; 6(5):565-71. PubMed ID: 16934729 [TBL] [Abstract][Full Text] [Related]
18. Minutes to recovery after a hemodialysis session: a simple health-related quality of life question that is reliable, valid, and sensitive to change. Lindsay RM; Heidenheim PA; Nesrallah G; Garg AX; Suri R; Clin J Am Soc Nephrol; 2006 Sep; 1(5):952-9. PubMed ID: 17699312 [TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study. Tanriverdi-Akhisaroglu S; Menderes A; Oktay G Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813 [TBL] [Abstract][Full Text] [Related]
20. Treatment of hypertrophic and keloid scars with SILASTIC Gel Sheeting. Dockery GL; Nilson RZ J Foot Ankle Surg; 1994; 33(2):110-9. PubMed ID: 7912605 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]